Picture of Eden Research logo

EDEN Eden Research News Story

0.000.00%
gb flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapSucker Stock

REG - Eden Research plc - Grant of Awards Under Long-Term Incentive Plan

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240705:nRSE2402Va&default-theme=true

RNS Number : 2402V  Eden Research plc  05 July 2024

05 July 2024

 

Eden Research plc

 

("Eden" or "Company)

 

Grant of Awards Under Long-Term Incentive Plan

 

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable
biopesticides and plastic-free formulation technology for use in global crop
protection, animal health and consumer products industries, confirms the grant
of options under the Company's Long Term Incentive Plan ("LTIP") to Sean
Smith, Chief Executive Officer, and Alex Abrey, Chief Finance Officer
(together the "Executives"), as follows:

 

The Company has made a grant to the Executives, in respect of 2023 in order to
ensure continuity of long term incentive, of options over 11,918,901 new
Ordinary Shares in Eden ("the Options"), at a strike price of 6.5p each,
representing a premium of 48% to the current share price, in the amounts of
6,805,852 awarded to Sean Smith and 5,113,049 awarded to Alex Abrey.

 

The Options expire on 30 June 2028 and vest as follows:

 

1/3 12 months from the date of grant

1/3 24 months from the date of grant

1/3 36 months from the date of grant

 

The notifications below, made in accordance with the requirements of the EU
Market Abuse Regulation, provide further detail.

 

 

For further information contact:

 

 Eden Research plc                                                 www.edenresearch.com (http://www.edenresearch.com/)
 Sean Smith                                                        01285 359 555

Alex Abrey

 Cavendish Capital Markets Limited (Nominated advisor and broker)
 Giles Balleny / George Lawson (corporate finance)                 020 7397 8900

Michael Johnson (sales)

 Hawthorn Advisors (Financial PR)
 Victoria Ainsworth                                                eden@hawthornadvisors.com (mailto:eden@hawthornadvisors.com)

 

 

 

 

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Sean Smith

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Eden Research plc

 b)   LEI                                                          213800ZWTYTVQQSM3J85

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Options over ordinary shares of 1 pence each

      Identification code

                                                                   GB0001646941
 b)   Nature of the transaction                                    Grant of options

 c)   Price(s) and volume(s)                                       Price(s)  Volume(s)

                                                                   6.5p      6,805,852
 d)   Aggregated information

      - Aggregated volume

      - Price                                                      N/A

 e)   Date of the transaction                                      4 July 2024

 f)   Place of the transaction                                     Outside of trading venue

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

 

N/A

e)

 

Date of the transaction

 

4 July 2024

f)

 

Place of the transaction

 

Outside of trading venue

 

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Alex Abrey

 2    Reason for the notification

 a)   Position/status                                              Chief Financial Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Eden Research plc

 b)   LEI                                                          213800ZWTYTVQQSM3J85

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Options over ordinary shares of 1 pence each

      Identification code

                                                                   GB0001646941
 b)   Nature of the transaction                                    Grant of options

 c)   Price(s) and volume(s)                                       Price(s)  Volume(s)

                                                                   6.5p      5,113,049
 d)   Aggregated information

      - Aggregated volume

      - Price                                                      N/A

 e)   Date of the transaction                                      4 July 2024

 f)   Place of the transaction                                     Outside of trading venue

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

 

N/A

e)

 

Date of the transaction

 

4 July 2024

f)

 

Place of the transaction

 

Outside of trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSSLFWLELSESW

Recent news on Eden Research

See all news